Oorja Bio
Latest round
- Series A
Last raised
- May 2026
Total raised
- $20M
Investors
- 1
About Oorja Bio
Oorja Bio, Inc. is a Houston-based biopharmaceutical company specializing in innovative therapies for cardiopulmonary and fibrotic disorders, focusing on addressing the underlying causes of these diseases. Founded in 2023 by Sujay Kango, Founder & Chief Executive Officer; Janethe Pena, Co-Founder & Chief Medical Officer; and Connie Coulomb, Co-Founder & Chief Business Officer, Oorja Bio, Inc. operates in the biopharmaceutical industry and is dedicated to developing treatments for serious fibrotic diseases. The company is located in Houston, US and focuses primarily on clinical-stage drug development.. The current CEO is Sujay Kango. In May 2026, Oorja Bio, Inc. Oorja Bio specializes in developing innovative therapies specifically targeting cardiopulmonary and fibrotic disorders. Their core product, ORJ-001, is a first-in-class peptide therapeutic designed for subcutaneous administration aimed at treating idiopathic pulmonary fibrosis (IPF). ORJ-001 works by restoring the function of alveolar epithelial type 2 (AEC2) cells, promoting alveolar repair and reducing the inflammatory and fibrotic signaling associated with pulmonary fibrosis.Oorja Bio operates primarily within a clinical development framework, focusing on partnerships and collaborations within the biopharmaceutical sector to generate revenue.In May 2026, Oorja Bio, Inc. The company plans to launch additional products addressing fibrotic diseases and aims to penetrate new markets in both the United States and Europe.
Who invested in Oorja Bio
1 investor across 1 round
See all investors in Oorja Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 19, 2026
Amount
$20M
Investors
Questions about Oorja Bio
Who invested in Oorja Bio?
Oorja Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oorja Bio raised?
Oorja Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oorja Bio last raise money?
Oorja Bio's most recent round on record is a Series A, in May 2026.
What does Oorja Bio do?
Oorja Bio is a biotechnology company.
Where is Oorja Bio headquartered?
Oorja Bio is headquartered in Houston, US.
Which VCs invest in companies like Oorja Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Oorja Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Oorja Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.